首页 | 本学科首页   官方微博 | 高级检索  
检索        

血液病受血者抗—HCV检测
引用本文:刘竞,蒋铁斌,文锋.血液病受血者抗—HCV检测[J].湖南医科大学学报,2003,28(2):180-182.
作者姓名:刘竞  蒋铁斌  文锋
摘    要:目的:观测血液病受血者丙型肝炎病毒(HCV)感染情况,探讨输血前抗-HCV的检测意义。方法:采用酶联免疫吸附法(ELISA)检测血液病受血者抗-HCV。观测输血前血液病受血者176例,输血后追踪观察6-12月完成复查95例;并设对照组417例。结果:血液病受血者输血前抗-HCV阳性率(5.68%,10/176)明显高于对照组(0.72%,3/417;P<0.01)和普外科患者(2.23%,21/942;P<0.05)。输血后无新感染病例发生。结论:血液病患者输血前HCV感染值得关注,开展输血前抗-HCV检测是必要的。

关 键 词:血液病  受血者  抗-HCV  检测  酶联免疫吸附法

Detection of anti-HCV in blood recipients with hematonosis]
Jing Liu,Tie-bin Jiang,Feng Wen.Detection of anti-HCV in blood recipients with hematonosis][J].Bulletin of Hunan Medical University,2003,28(2):180-182.
Authors:Jing Liu  Tie-bin Jiang  Feng Wen
Institution:Department of Hematology, Third Xiangya Hospital, Central South University, Changsha 410013, China.
Abstract:OBJECTIVE: To observe hepatitis C virus (HCV) infection in blood recipients with hematonosis, and to investigate the significance of anti-HCV detection in the patients. METHODS: Anti-HCV was detected by enzyme-linked immunosorbent assay (ELISA) in 176 hematonosis patients before blood transfusion, the result of anti-HCV was compared with control (417 cases), and 95 blood recipients were followed up for 6-12 months after the transfusion. RESULTS: The positive rate of anti-HCV was 5.68% (10/176) in hematonosis patients before transfusion, higher than both in the control 0.72% (3/417), P < 0.01] and in the patients with general surgery 2.23% (21/942), P < 0.05], and no new infection case was found after the transfusion. CONCLUSION: HCV infectionin in blood recipients with hematonosis should be paid attention to, and the detection of anti-HCV is necessary for patients before blood transfusion.
Keywords:
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号